IsoRay, Inc. (NYSEMKT: ISR) IsoRay stock had an incredible day in the market yesterday; showing gains of more than 100%. However, today the story seems to have changed. Unfortunately, the trend has turned directions and the value of …
I've been following IsoRay for quite some time now. Ever since I heard about Cesium-131, I've been interested in the company. While the stock hasn't performed well over the past year, I believe that current data coming out with regard to …
IsoRay, Inc. (NYSE MKT:ISR) has had a very interesting time in the market this week. After releasing positive data revolving around Cesium-131, the company’s stock skyrocketed; gaining more than 100% in a single day. However, …
IsoRay (ISR) climbed on Monday after the medical technology company announced a new human prostate implant to help treat prostate cancer. IsoRay unveiled the world's first human prostate cancer implant using its Cesium-131 seeds and …
The boss of ISR Capital - one of the firms caught up in the fallout from the 2013 penny stock crash - has quit. Ms Quah Su-Yin stepped down as chief executive and executive director of the investment firm last Saturday, according to a …
The Malaysian businessman is the alleged mastermind behind the penny stock saga of 2013. He has already been held ... That very day, shares in ISR Capital …
Media headlines about IsoRay (NYSEMKT:ISR) have been trending somewhat positive on Friday, according to AlphaOne Sentiment Analysis. The research group, a subsidiary of Accern, ranks the sentiment of news coverage by monitoring …
Richland-based IsoRay (NYSE: ISR), which makes radioactive seeds to treat cancers, said the results of a study conducted by researchers at Barrow Neurological Institute, of the 27 patients in the study, 26 "had not experienced a …
The latest mining stock additions are both Canadian Stock Exchange (CSE ... AbbVie employs more than 28,000 people worldwide and markets medicines in more than 170 countries. IsoRay, Inc. (NYSE MKT: ISR) designs and develops …
MENAFN4mon